Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (Weighted Average): 2014-2024

Historic Shares Outstanding (Weighted Average) for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to $32.3 million.

  • Collegium Pharmaceutical's Shares Outstanding (Weighted Average) fell 2.21% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 million, marking a year-over-year decrease of 2.21%. This contributed to the annual value of $32.3 million for FY2024, which is 1.11% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Shares Outstanding (Weighted Average) stood at $32.3 million for FY2024, which was down 1.11% from $32.6 million recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Shares Outstanding (Weighted Average) peaked at $34.6 million during FY2020, and registered a low of $32.3 million during FY2024.
  • Over the past 3 years, Collegium Pharmaceutical's median Shares Outstanding (Weighted Average) value was $32.6 million (recorded in 2023), while the average stood at $32.8 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first grew by 3.15% in 2020, then dropped by 2.88% in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Shares Outstanding (Weighted Average) (Yearly) stood at $34.6 million in 2020, then fell by 0.04% to $34.6 million in 2021, then fell by 2.88% to $33.6 million in 2022, then fell by 2.86% to $32.6 million in 2023, then declined by 1.11% to $32.3 million in 2024.